Hans Preusting
Director/Board Member at MENDUS AB
Network origin in Hans Preusting first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
 Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands.
22
| Extinct | Miscellaneous Commercial Services | 22 |
17
| Public Company | Biotechnology | 17 |
DCPrime BV
 DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
PharmaCell BV
 PharmaCell BV BiotechnologyHealth Technology PharmaCell BV manufactures cell therapy and regenerative medicine. The firm engages in human cell line development and manufacturing of bio pharmaceuticals. Its services include process research and development, project management, incoming logistics, incoming goods, manufacturing auto logous and allogeneic products, quality control, final formulation, release and outgoing logistics. The company was founded by René Lardenoije and Jan Thio in 2005 and is headquartered in Maastricht, the Netherlands.
5
| Subsidiary | Biotechnology | 5 |
Oxyrane UK Ltd.
 Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Abbott Healthcare Products BV
 Abbott Healthcare Products BV Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Healthcare Products BV is a Dutch company that manufactures and distributes pharmaceuticals. The company is based in Weesp, Netherlands.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Synerkine Pharma BV
 Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
DSM Biologics Holding, Inc.
 DSM Biologics Holding, Inc. BiotechnologyHealth Technology Part of DSM BV, DSM Biologics Holding, Inc. is a Canadian company that manufactures biological and pharmaceutical products. The company is based in Montréal, Canada. The company was founded by Jos van Weperen. DSM Biologics Holding was acquired by DSM Pharmaceuticals, Inc., a subsidiary of DSM BV from Province of Québec on July 13, 2005.
1
| Subsidiary | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hans Preusting via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| UNIQURE N.V. | Biotechnology | Director/Board Member Chairman Chief Executive Officer Director/Board Member Founder Founder Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Amsterdam | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Leiden | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Ghent University | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
NewAmsterdam Pharma BV
 NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Founder Chairman Director/Board Member | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Founder | |
Sahlgrenska Universitetssjukhuset
 Sahlgrenska Universitetssjukhuset Hospital/Nursing ManagementHealth Services Sahlgrenska Universitetssjukhuset engages in the provision of basic and emergency medical care. It offers specialized care, pediatrics, transplant activity, treatment of cardiovascular diseases, immunology, and vaccine research. Its hospital provides an infrastructure necessary for teaching and research. The company was founded on January 1, 1997 and is based in Gothenburg, Sweden. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member Chairman | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree | |
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree Undergraduate Degree | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Chief Executive Officer | |
| HOOKIPA PHARMA INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin | |
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Medical Specialties | Chief Executive Officer Director/Board Member | |
| University of Lund | College/University | Doctorate Degree Undergraduate Degree | |
| Erasmus University Rotterdam | College/University | Doctorate Degree Graduate Degree | |
| MEDIVIR AB | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| Vlerick Leuven Gent Management School | College/University | General Counsel Corporate Officer/Principal | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Doctorate Degree | |
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
| ELICERA THERAPEUTICS AB | Biotechnology | Director/Board Member General Counsel | |
VectorY BV
 VectorY BV Miscellaneous Commercial ServicesCommercial Services VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin | |
| TIGENIX NV | Medical Specialties | Director/Board Member Founder | |
| Swiss Federal Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| Vimalan Biosciences, Inc. | Director/Board Member | ||
Aventis Pharma SARL
 Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the company is based in Antony, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Celgene International SARL
 Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the company is based in Boudry, Switzerland. | Pharmaceuticals: Major | President | |
| Actinova AB | Director/Board Member | ||
| Active Security Trading AB | Chairman | ||
| SAVICORP | Movies/Entertainment | Chief Executive Officer | |
Xoft, Inc.
 Xoft, Inc. Data Processing ServicesTechnology Services Xoft, Inc. develops Electronic Brachytherapy systems for radiation therapy applications. Its products include the Axxent Controller, which utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed; Axxent HDR X-ray Source, a low energy radiation treatment without the use of radioactive isotopes; Axxent Applicators, which provides a channel for the Axxent X-ray Source to deliver high dose rate, low energy radiation directly to the targeted area; and Axxent Accessories, an accessory product line designed to support and aid a physician during a procedure or treatment of cancer radiation. The company was founded by Michael Forman in 1998 and is headquartered in San Jose, CA. | Data Processing Services | Director/Board Member | |
Lanthio Pharma BV
 Lanthio Pharma BV Medical SpecialtiesHealth Technology Lanthio Pharma BV focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics. Its product is a lanthionine-stabilized specific agonist of the AT2 receptor, which has great potential in diseases where tissue protection is important, like fibrosis. The company was founded in 2010 and is headquartered in Groningen, the Netherlands. | Medical Specialties | Corporate Officer/Principal | |
Paragraf Ltd.
 Paragraf Ltd. Electrical ProductsProducer Manufacturing Paragraf Ltd. operates as a graphene technology development firm. Its products include graphene layers, heterostructures, thin film material heterostructures, and graphene devices as well as novel 2D materials. The company was founded on November 25, 2015 and is headquartered in , the Cambridgeshire,United Kingdom. | Electrical Products | Director/Board Member | |
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Biotechnology | Chief Tech/Sci/R&D Officer | |
K2M, Inc.
 K2M, Inc. Medical SpecialtiesHealth Technology K2M, Inc. manufactures and markets medical devices. It offers deformity correction systems, spinal stabilization systems, lateral access systems, minimally invasive systems, and, constrained and translational cervical plates. The company was founded by John Philip Kostuik and Eric Major in January 2004 and is headquartered in Leesburg, VA. | Medical Specialties | Director/Board Member | |
Zeotap GmbH
 Zeotap GmbH Miscellaneous Commercial ServicesCommercial Services zeotap GmbH offers a solution for telecom operators. It provides a technology platform that transmits data securely and in a privacy-compliant way for businesses and consumers. The company was founded by Daniel Heer, Stephan Schwebe and Projjol Banerjea and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Ferric, Inc. (New York)
 Ferric, Inc. (New York) Electronic ComponentsElectronic Technology Ferric, Inc. develops integrated circuits and integrated inductors in CMOS technology for use in on-chip voltage regulators. Its products include chips and circuit IP, power management IC, packaged integrated voltage regulators and stack integrated voltage regulators. The firm offers power converters utilizing inductors. Its technology can be applies across a broad spectrum of power electronics ranging from full scale servers to the chip level. The company was founded in 2011 by Noah Sturcken, Maurizio Arienzo and Kenneth Shepard and is headquartered in New York, NY. | Electronic Components | Director/Board Member | |
Brightvolt Solid State Batteries
 Brightvolt Solid State Batteries Electrical ProductsProducer Manufacturing Brightvolt Solid State Batteries provides embedded power solutions. It also develops custom solid state thin film batteries and power solutions for client’s IoT devices; flexion solid state thin film lithium polymer batteries; and thin micro electronics. The company was founded by Robert Singleton and Craig Nelson in 2001 and is headquartered in Redmond, WA. | Electrical Products | Director/Board Member | |
| Gene Therapy Systems, Inc. | Director/Board Member |
Statistics
International
| United States | 14 |
| Sweden | 13 |
| Netherlands | 12 |
| Belgium | 5 |
| Switzerland | 4 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Producer Manufacturing | 3 |
| Finance | 2 |
Operational
| Director/Board Member | 277 |
| Corporate Officer/Principal | 109 |
| Chief Executive Officer | 54 |
| Independent Dir/Board Member | 50 |
| Chief Tech/Sci/R&D Officer | 48 |
Most connected contacts
| Insiders | |
|---|---|
| Somu Subramaniam | 48 |
| Hugo Slootweg | 34 |
| Steven Holtzman | 28 |
| Ferdinand Verdonck | 25 |
| Dharminder Singh Chahal | 25 |
| Leonard Post | 25 |
| Sven Arne Andréasson | 24 |
| Joseph Feczko | 23 |
| Ted Ingemar Jakob Fjällman | 23 |
| Sven Rohmann | 20 |
| François Meyer | 20 |
| Piers John Morgan | 18 |
| Sander J. van Deventer | 17 |
| Lutgart A. A. van den Berghe | 17 |
| George Morstyn | 17 |
- Stock Market
- Insiders
- Hans Preusting
- Company connections
